查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404586

臉部注射劑市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2023-2030

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Hyaluronic Acid), By Application (Facial Line Correction, Face Lift), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 172 Pages | 商品交期: 2-10個工作天內

價格

臉部注射劑市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球臉部注射劑市場規模預計將達到249.2億美元，2023年至2030年複合年成長率為12.0%。臉部注射劑在抗老化治療中極為重要，特別是當用於阻止色素沉著過度和過早衰老等損傷時。

所有社會經濟群體中最受歡迎的治療方法是肉毒桿菌和填充劑，它們已經獲得了極大的歡迎。

人們越來越重視外觀，尤其是在新興國家，這是預計推動市場的關鍵因素之一。此外，消費者對微創手術偏好的改變也預計將支持市場成長。根據美國整形外科醫生協會 (ASPS) 的數據，A 型肉毒桿菌和軟組織填充劑是 2020 年美國實施的前五名微創手術之一。

受疫情影響，2020年第一季、第二季度非緊急整形手術暫停。冠狀病毒的爆發影響了包括化妝品行業在內的所有行業，當局實施了嚴格的限制作為預防措施。美容產品的供應鏈也受到影響。整個醫療設備產業的供需鏈受到疫情的嚴重干擾。

臉部注射劑市場報告亮點

  • 按產品類型分類，A 型肉毒桿菌素預計將在整個預測期主導市場。這是最常用的微創手術之一。
  • 從應用來看，麵線矯正領域佔據市場主導地位，2022 年收益佔有率最大，為 33.2%。這種成長是由於擴大使用臉部注射劑進行美容手術，例如臉部細紋、臉部皺紋和唇紋。
  • 根據最終用途，醫療保健細分市場佔據主導地位，2022 年收益佔有率最大，為 46.8%。所有非侵入性治療均由經驗豐富的專業人員在這些設施中進行，包括臉部注射、非侵入性身體輪廓、活膚和雷射治療。
  • 由於產品容易取得且擁有大量熟練的外科醫生，北美在 2022 年以 39.7% 的銷售佔有率佔據市場主導地位。
  • 預計亞太地區將成為主要的產生收入中心。該地區得到了印度等國家的支持，人們對外觀的日益關注預計將為該市場創造利潤豐厚的機會。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球臉部注射劑市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 臉部注射市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臉部注射劑市場：產品預估及趨勢分析

  • 定義和範圍
  • 2022年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品分類的全球臉部注射劑市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第5章臉部注射劑市場：使用量估算與趨勢分析

  • 定義和範圍
  • 2022年及2030年應用市場佔有率
  • 細分儀表板
  • 全球臉部注射劑市場按應用前景展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章臉部注射劑市場：最終用途估計和趨勢分析

  • 定義和範圍
  • 2022 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球注射劑市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第7章臉部注射劑市場：按地區估計和趨勢分析

  • 2022 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2020年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、數量與趨勢分析：
  • 北美洲
    • 2018年至2030年北美臉部注射劑市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018年至2030年歐洲臉部注射劑市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太地區臉部注射劑市場估計與預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲臉部注射劑市場估計與預測，2018-2030 年
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年MEA臉部注射劑市場估計與預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 主要製造商的最新發展和影響分析
  • 公司簡介（製造商）
    • Ispen
    • Abbvie（Allergen）
    • Merz Pharma
    • Galderma
    • Revance Therapeutics
    • Sinclair Pharma
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 24.92 billion by 2030, registering a CAGR of 12.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.,The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights:

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2022. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 46.8% in 2022. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 39.7% in 2022 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
    • 1.3.6. Data for primary interviews in North America
    • 1.3.7. Data for primary interviews in Europe
    • 1.3.8. Data for primary interviews in Asia Pacific
    • 1.3.9. Data for primary interviews in Latin America
    • 1.3.10. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Approach 1: Commodity flow analysis
    • 1.6.2. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing aging population
      • 3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory constrains
      • 3.2.2.2. High cost of procedures
  • 3.3. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Collagen & PMMA Microspheres
    • 4.1.2. Hyaluronic Acid (HA)
    • 4.1.3. Botulinum Toxin Type A
    • 4.1.4. Calcium Hydroxylapatite (CaHA)
    • 4.1.5. Poly-L-lactic Acid (PLLA)
    • 4.1.6. Others
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Facial Injectable Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Collagen & PMMA Microspheres
      • 4.5.1.1. Collagen & PMMA Microspheres market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.2. Hyaluronic Acid (HA)
      • 4.5.2.1. Hyaluronic Acid (HA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.3. Calcium Hydroxylapatite (CaHA)
      • 4.5.3.1. Calcium Hydroxylapatite (CaHA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.4. Poly-L-lactic Acid (PLLA)
      • 4.5.4.1. Poly-L-lactic Acid (PLLA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Facial Line Correction
    • 5.1.2. Lip Augmentation
    • 5.1.3. Face Lift
    • 5.1.4. Acne Scar Treatment
    • 5.1.5. Lipoatrophy Treatment
    • 5.1.6. Others
  • 5.2. Application Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Facial Injectable Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Facial Line Correction
      • 5.5.1.1. Facial Line Correction market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.2. Lip Augmentation
      • 5.5.2.1. Lip Augmentation market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.3. Face Lift
      • 5.5.3.1. Face Lift market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.4. Acne Scar Treatment
      • 5.5.4.1. Acne Scar Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.5. Lipoatrophy Treatment
      • 5.5.5.1. Lipoatrophy Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Facial Injectable Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Medspas
    • 6.1.2. Dermatology Clinics
    • 6.1.3. Hospitals
  • 6.2. End-use Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Injectable Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Medspas
      • 6.5.1.1. Medspas market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.2. Dermatology Clinics
      • 6.5.2.1. Dermatology Clinics market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.3. Hospitals
      • 6.5.3.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2020
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. North America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
    • 7.7.3. Canada
      • 7.7.3.1. Canada Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
  • 7.8. Europe
    • 7.8.1. Europe Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.2. UK
      • 7.8.2.1. UK Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.2.2. Key Country Dynamics
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Regulatory Framework
    • 7.8.3. Germany
      • 7.8.3.1. Germany Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.3.2. Key Country Dynamics
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Regulatory Framework
    • 7.8.4. France
      • 7.8.4.1. France Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.4.2. Key Country Dynamics
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Regulatory Framework
    • 7.8.5. Italy
      • 7.8.5.1. Italy Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.5.2. Key Country Dynamics
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Regulatory Framework
    • 7.8.6. Spain
      • 7.8.6.1. Spain Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.6.2. Key Country Dynamics
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Regulatory Framework
    • 7.8.7. Sweden
      • 7.8.7.1. Sweden Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.7.2. Key Country Dynamics
      • 7.8.7.3. Competitive Scenario
      • 7.8.7.4. Regulatory Framework
    • 7.8.8. Norway
      • 7.8.8.1. Norway Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.8.2. Key Country Dynamics
      • 7.8.8.3. Competitive Scenario
      • 7.8.8.4. Regulatory Framework
    • 7.8.9. Denmark
      • 7.8.9.1. Denmark Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.9.2. Key Country Dynamics
      • 7.8.9.3. Competitive Scenario
      • 7.8.9.4. Regulatory Framework
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.2. China
      • 7.9.2.1. China Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.2.2. Key Country Dynamics
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Regulatory Framework
    • 7.9.3. Japan
      • 7.9.3.1. Japan Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.3.2. Key Country Dynamics
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. Regulatory Framework
    • 7.9.4. India
      • 7.9.4.1. India Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.4.2. Key Country Dynamics
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Regulatory Framework
    • 7.9.5. Australia
      • 7.9.5.1. Australia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.5.2. Key Country Dynamics
      • 7.9.5.3. Competitive Scenario
      • 7.9.5.4. Regulatory Framework
    • 7.9.6. Thailand
      • 7.9.6.1. Thailand Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.6.2. Key Country Dynamics
      • 7.9.6.3. Competitive Scenario
      • 7.9.6.4. Regulatory Framework
    • 7.9.7. South Korea
      • 7.9.7.1. South Korea Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.7.2. Key Country Dynamics
      • 7.9.7.3. Competitive Scenario
      • 7.9.7.4. Regulatory Framework
  • 7.10. Latin America
    • 7.10.1. Latin America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.2.2. Key Country Dynamics
      • 7.10.2.3. Competitive Scenario
      • 7.10.2.4. Regulatory Framework
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.3.2. Key Country Dynamics
      • 7.10.3.3. Competitive Scenario
      • 7.10.3.4. Regulatory Framework
    • 7.10.4. Argentina
      • 7.10.4.1. Argentina Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.4.2. Key Country Dynamics
      • 7.10.4.3. Competitive Scenario
      • 7.10.4.4. Regulatory Framework
  • 7.11. MEA
    • 7.11.1. MEA Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Saudi Arabia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.2.2. Key Country Dynamics
      • 7.11.2.3. Competitive Scenario
      • 7.11.2.4. Regulatory Framework
    • 7.11.3. South Africa
      • 7.11.3.1. South Africa Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.3.2. Key Country Dynamics
      • 7.11.3.3. Competitive Scenario
      • 7.11.3.4. Regulatory Framework
    • 7.11.4. UAE
      • 7.11.4.1. UAE Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.4.2. Key Country Dynamics
      • 7.11.4.3. Competitive Scenario
      • 7.11.4.4. Regulatory Framework
    • 7.11.5. Kuwait
      • 7.11.5.1. Kuwait Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.5.2. Key Country Dynamics
      • 7.11.5.3. Competitive Scenario
      • 7.11.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company Profiles (Manufacturers)
    • 8.2.1. Ispen
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbvie (Allergen)
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Merz Pharma
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Galderma
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Revance Therapeutics
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Sinclair Pharma
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Facial Injectable Market: market outlook
  • Fig. 9 Facial Injectable Market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Global Facial Injectable Market driver impact
  • Fig. 14 Global Facial Injectable Market restraint impact
  • Fig. 15 Global Facial Injectable Market strategic initiatives analysis
  • Fig. 16 Global Facial Injectable Market: Product movement analysis
  • Fig. 17 Global Facial Injectable Market: Product outlook key takeaways
  • Fig. 18 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Poly-L-lactic Acid (PLLA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Global Facial Injectable Market: Application movement analysis
  • Fig. 25 Global Facial Injectable Market: Application outlook and key takeaways
  • Fig. 26 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Lip Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Face Lift market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Acne Scar Treatment Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Global Facial Injectable Market: End-use movement analysis
  • Fig. 33 Global Facial Injectable Market: End-use outlook and key takeaways
  • Fig. 34 Medspas market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Global Facial Injectable Market: regional movement analysis
  • Fig. 38 Global Facial Injectable Market: regional outlook and key takeaways
  • Fig. 39 North America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 France Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Norway Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 China Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 India Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Australia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Thailand Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Middle East and Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Saudi Arabia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)